Pain Management during Rehabilitation after Distal Radius Fracture Stabilized with Volar Locking Plate: A Prospective Cohort Study
Table 3
Functional outcomes at one, three, and six months postoperatively.
Celecoxib (n=149)
Transdermal buprenorphine (n=89)
Codeine/ ibuprofen (n=77)
P value
One month
PRWE
40 (13)#
26 (10)
24 (11)
< 0.01
PRWE (pain subscale)
14 (6)
13 (5)
12 (6)
0.63
DASH
42 (16)#
30 (14)
32 (12)
< 0.01
Grip strength (%)
45 (13)
46 (21)
47 (20)
0.78
Extension (%)
43 (16) #
61 (18)
60 (15)
< 0.01
Flexion (%)
60 (21) #
71 (22)
71 (18)
< 0.01
Pronation (%)
80 (21)
79 (24)
83 (20)
0.55
Supination (%)
54 (16) #
60 (22)
60 (28)
0.03
Ulnar abduction (%)
45 (18) #
60 (15)
61 (19)
< 0.01
Radial abduction (%)
50 (23) #
57 (21)
59 (26)
0.01
Three months
PRWE
18 (8) #
16 (6)
16 (7)
0.04
PRWE (pain subscale)
5 (2)
6 (3)
5 (3)
0.67
DASH
25 (9) #
21 (7)
20 (7)
< 0.01
Grip strength (%)
91 (9)
91 (7)
90 (9)
0.79
Extension (%)
73 (17) #
78 (20)
80 (26)
0.02
Flexion (%)
78 (30)
84 (22)
87 (23)
0.04
Pronation (%)
90 (10)
93 (16)
91 (12)
0.21
Supination (%)
60 (21) #
68 (27)
67 (28)
0.02
Ulnar abduction (%)
65 (18) #
78 (21)
76 (25)
< 0.01
Radial abduction (%)
68 (19) #
75 (23)
75 (26)
0.03
Six Months
PRWE
5( 3)
6 (3)
5 (3)
0.28
PRWE (pain subscale)
3 (2)
3 (2)
2 (1)
0.81
DASH
8 (3)
8 (5)
8 (3)
0.95
Grip strength (%)
90 (10)
89 (9)
91 (6)
0.46
Extension (%)
92 (12)
92 (10)
91 (8)
0.81
Flexion (%)
93 (11)
96 (10)
93 (9)
0.12
Pronation (%)
93 (6)
93 (8)
92 (10)
0.76
Supination (%)
90 (11)
90 (13)
88 (15)
0.26
Ulnar abduction (%)
86 (15) #
91 (12)
90 (13)
0.01
Radial abduction (%)
88 (17) #
93 (15)
93 (15)
0.04
Figures are mean (SD). P < 0.05 versus celecoxib group; # P < 0.05 versus transdermal buprenorphine group. P value was calculated using Student’s t-test.
